Theramex

News

woman suffering from uterine fibroid pain holding her abdomen

Theramex's uterine fibroid drug Yselty backed for NHS use

A daily oral therapy for uterine fibroids has been recommended for NHS by NICE, providing a new option for around 30,000 women in England and Wales.

News

NICE backs osteoporosis drug, but diagnosis is an obstacle

Around 14,000 women in England may soon be able to access a new treatment for osteoporosis after NICE backed routine NHS use of Theramex's Eladynos.

News

Mature Woman Experiencing Hot Flush From Menopause

Scottish Medicines Consortium accepts Theramex' Bijuve HRT o...

The first and only body-identical HRT for post-menopausal oestrogen deficiency, Bijuve, has been passed by the SMC as suitable for use by Scotland’s National Health Service, after being adv

Theramex's uterine fibroid drug Yselty backed for NHS use

NICE backs osteoporosis drug, but diagnosis is an obstacle

Scottish Medicines Consortium accepts Theramex' Bijuve HRT o...

OpenBind unveils its first AI model for drug discovery

Discover a new era of healthcare panel engagement: Grounded ...

Editor's Picks